TCCC Guidelines 2026: What Changed, What It Means, and How to Stay Current
Tactical Medicine • TCCC • CoTCCC Guidelines
TCCC Guidelines 2026: What Changed, What It Means, and How to Stay Current
The CoTCCC has issued multiple significant updates since 2024 — including a complete airway management overhaul, a landmark antibiotic change from ertapenem to ceftriaxone (Change 25-1), a TXA policy shift eliminating the 3-hour window, and a proposed tourniquet reassessment standard (Change 25-2) driven by Russo-Ukrainian War data. Here is everything you need to know to stay mission-ready in 2026.
Update Your Kit to Match Current TCCC Guidelines
MED-TAC carries CoTCCC-compliant equipment for every phase of care — from CUF to TACEVAC.
Hemorrhage Control Airway Management IFAK KitsWhat Is TCCC and Why Does It Matter?
Direct answer: Tactical Combat Casualty Care (TCCC) is the U.S. military standard for prehospital trauma care in combat environments. It is an evidence-based framework that dictates how casualties are assessed and treated from the moment of wounding through evacuation to a medical treatment facility. Maintained by the Committee on Tactical Combat Casualty Care (CoTCCC) under the Joint Trauma System (JTS), TCCC has become the most consequential advancement in battlefield medicine in modern history.
The story of TCCC begins not on a modern battlefield, but in a recognition born out of loss. Analysis of Vietnam-era combat deaths established that a staggering proportion of fatalities were occurring before casualties ever reached a surgeon. Hemorrhage, airway compromise, and tension pneumothorax — conditions that skilled hands can address in the field — were the killers.
In 1996, Drs. Frank Butler, John Hagmann, and George Butler published the foundational TCCC article in Military Medicine, formally integrating combat tactics with evidence-based trauma care for the first time. The core insight was both simple and revolutionary: the best trauma care is useless if the person providing it becomes a casualty themselves, and most combat deaths happen before evacuation. TCCC was built around those two realities.
The CoTCCC was formally established in 2001, coinciding with the onset of major combat operations in Afghanistan. Since then, it has operated as the scientific engine behind guideline evolution — reviewing battlefield data, commissioning research, and issuing changes through the Journal of Special Operations Medicine (JSOM).
The Three Phases of TCCC
TCCC organizes care into three operationally distinct phases:
- Care Under Fire (CUF): Minimal interventions — tourniquet application and returning fire — while actively engaged with a threat.
- Tactical Field Care (TFC): The workhorse phase. When relative cover is available, the medic conducts a systematic MARCH assessment and initiates definitive prehospital interventions.
- Tactical Evacuation Care (TACEVAC): Sustained care during movement to a Role 2 or Role 3 facility. (Note: airway responsibilities in this phase have been formally transferred to the Committee on Enroute Combat Casualty Care as of Change 24-1.)
The Impact: By the Numbers
The 75th Ranger Regiment achieved the virtual elimination of preventable combat death by institutionalizing TCCC training for every soldier — not just medics. This data-driven model, documented in JAMA Surgery (2011), became the DoD-wide recommendation. The lesson has never been clearer: TCCC works, and keeping current with its guidelines is a life-or-death professional obligation.
What Changed in the TCCC Guidelines for 2025–2026?
Direct answer: The CoTCCC issued two formal changes and one additional proposed change between 2024 and early 2026. Change 24-1 overhauled airway management by removing supraglottic airways from Tactical Field Care. Change 25-1 replaced ertapenem with ceftriaxone 2g as the parenteral antibiotic of choice. Proposed Change 25-2 addresses tourniquet reassessment standards informed by Russo-Ukrainian War casualty data. Additionally, the TXA administration window has been formally revised. These are the most substantive updates to TCCC since the hemorrhage control revolution of the mid-2000s.
| Change | Category | Previous Guideline | Updated Guideline | Rationale |
|---|---|---|---|---|
| 24-1 | Airway — Device | Supraglottic/extraglottic airway (EGA) recommended in TFC | EGA removed from TFC; recovery position for unconscious casualties | No survival benefit vs. BVM; poorly tolerated in trauma without RSI; battlefield environmental issues |
| 24-1 | Airway — Positioning | Jaw thrust for unconscious casualties | Recovery position, head tilted back (chin away from chest); "Sit-Up and Lean-Forward" for conscious maxillofacial trauma | Extended position maximizes airway patency; simplified for high-stress environments |
| 24-1 | Airway — Cric Device | Control-Cric preferred for cricothyroidotomy | Control-Cric removed; standard kits based on training/availability; continuous capnography required post-cric | Control-Cric performed second or third in every evaluation category vs. other devices |
| 24-1 | Airway — NPA | NPA recommended in TFC airway sequence | NPA moved to Respiration/Breathing section; indicated only for SpO₂ <90% with BVM ventilation | Repositioned to context where evidence supports use |
| 24-1 | Airway — BVM | Standard BVM ventilation | 1,000 mL resuscitator BVM specified for ventilation in SpO₂ <90% with uncorrectable hypoxia | Smaller BVM reduces barotrauma and gastric inflation; lower peak pressures |
| 25-1 | Antibiotics — Parenteral | Ertapenem 1g IV/IO/IM once daily | Ceftriaxone 2g IV/IO/IM once daily | Point-of-wounding bacteria are Group A Strep, MSSA, C. perfringens — adequately covered by ceftriaxone; ertapenem associated with MDR A. baumannii emergence |
| 25-1 | Antibiotics — Oral | Moxifloxacin 400mg | Cefadroxil 1g (preferred); cephalexin 500mg (alternative) | Spectrum, side effects, stability, dosing, and cost advantages; antibiotic stewardship |
| TXA Update | Hemorrhage Control — TXA | Administer TXA within 3 hours of injury | Administer TXA as soon as possible after injury if hemorrhage suspected; no absolute time cap | CRITICAL study (12,000+ patients, Ukraine): effective up to 12 hours; 10% survival benefit lost per 15-minute delay reinforces immediacy, not restriction |
| 25-2 (Proposed) | Hemorrhage Control — Tourniquet | "Replacement" tourniquet terminology; limited guidance for non-medical personnel | Term changed to "repositioning"; all service members reassess within 2 hours; conversion beyond 2 hours limited to medical personnel | Russo-Ukrainian War data: excess ischemic complications from non-indicated tourniquet use and prolonged evacuation times |
Change 24-1: Airway Management Overhaul — What Actually Changed?
Published in the Journal of Special Operations Medicine (Shaw et al., Spring 2025), TCCC Change 24-1 represents the most significant revision to airway management doctrine since TCCC was formalized. The CoTCCC spent years challenging every dogmatic assumption, and the conclusions were counterintuitive to anyone trained in civilian EMS.
Supraglottic airways (SGAs) are out of Tactical Field Care. The I-gel and LMA-Supreme have been removed from the TFC algorithm. Why? Because without rapid sequence induction (RSI) — which TCCC does not support due to manpower, monitoring, and medication requirements — an SGA cannot be adequately placed in a trauma patient who is not profoundly unconscious. The evidence shows no survival benefit versus bag-valve-mask ventilation when used in true battlefield conditions, and the environmental limitations (extreme temperature, altitude during aeromedical evacuation) make them unreliable.
Recovery position is now first-line for unconscious casualties. If a casualty is unconscious but has no traumatic airway obstruction, place them in the lateral recovery position with the head tilted back and the chin away from the chest. The extended position demonstrates the most patent airway in studies — significantly better than mid or flexed positioning. The jaw thrust is no longer recommended in this context.
The Control-Cric is decommissioned as the preferred device. In structured evaluations, the Control-Cric performed second or third in every category compared to alternative surgical airway kits. Providers should train with the kit available to them. After any cricothyroidotomy, continuous capnography is now mandatory to confirm and monitor tube position — a critical patient safety addition.
Change 24-1 also formally removes TCCC airway management recommendations from the Tactical Evacuation Care (TACEVAC) phase entirely. That responsibility now belongs to the Committee on En Route Combat Casualty Care (CoERCCC). If you're writing SOPs for enroute care, reference the FY26 CoERCCC Guidelines, not the TCCC document.
Change 25-1: Why Did CoTCCC Abandon Ertapenem?
In late 2025, the CoTCCC issued TCCC Change 25-1, replacing ertapenem with ceftriaxone 2g as the recommended parenteral antibiotic — one of the most consequential pharmacological changes in TCCC history.
The rationale comes down to understanding what is actually on the wound at the point of injury versus what grows in a hospital days later. Research on casualties from the Ukrainian front line — with cultures taken a median of just 7 hours post-wounding, well before any medical treatment facility — identified the dominant point-of-wounding organisms as:
- Group A Streptococcus
- Methicillin-sensitive Staphylococcus aureus (MSSA)
- Clostridium perfringens (the cause of gas gangrene)
Ceftriaxone 2g covers all three appropriately. Ertapenem — a carbapenem — was always the stronger weapon, but the concern became: at what cost? Data from the Global War on Terror showed 86% of hospital-acquired multidrug-resistant organisms were Acinetobacter baumannii, with 91% carbapenem-resistant. The hypothesis held by many in the infectious disease community was that routine prehospital ertapenem use was contributing to that resistance pattern.
As Crisis Medicine summarized in February 2026: "Ceftriaxone provides appropriately broad coverage for point of wounding bacteria, while also maintaining antibiotic stewardship with a goal of reducing antibiotic-resistant infections."
Oral antibiotic update: Moxifloxacin has been replaced by cefadroxil 1g (preferred) or cephalexin 500mg (alternative), for the same stewardship and spectrum rationale.
2g IV/IO push over 3–5 minutes. Reconstitute with NS only — ceftriaxone precipitates with calcium-containing solutions (e.g., LR). Flush lines with 10–20 mL NS before and after. For IM administration: reconstitute with 4.2 mL NS or 1% lidocaine into a large muscle (lateral thigh preferred). Peak plasma concentration via IV/IO in ~30 minutes; IM absorption is delayed in hypotension — another reason to prefer IV/IO in the hemodynamically compromised casualty.
TXA Policy Update: The 3-Hour Window Is Gone
Tranexamic acid (TXA) has been in the TCCC guidelines since 2012 with a requirement to administer it within 3 hours of injury. That time restriction has now been removed. The CRITICAL study — conducted in Ukraine with over 12,000 patients — demonstrated that TXA remained effective up to 12 hours post-injury, reducing 28-day mortality by approximately 18% versus placebo.
The key survival principle hasn't changed: give it as early as possible. The CRASH-2 trial data shows a 10% loss in survival benefit for every 15-minute delay. But the removal of the 3-hour cutoff means medics are no longer forced to withhold TXA from a casualty they've been unable to reach in time. The guidance is now unambiguous: if hemorrhage is suspected, administer TXA as soon as possible. Ukraine also reported a 33% reduction in soldier mortality with widespread prehospital TXA use.
Proposed Change 25-2: Tourniquet Reassessment Standardization
Published in the Journal of Special Operations Medicine (March 2026), Proposed Change 25-2 addresses a problem the Russo-Ukrainian War made impossible to ignore: too many tourniquets applied when not medically indicated, and too many ischemic complications from tourniquets left too long due to extended evacuation timelines.
The proposed changes:
- Replace the term "replacement" with "repositioning" — a more precise description of what occurs.
- Establish a clear 2-hour reassessment window for all service members (non-medical).
- Limit tourniquet conversion beyond 2 hours to medical personnel only, with proper assessment criteria.
- Expand lifesaving capability to non-medical responders through plain-language, time-based guidance aligned with NATO partner standards.
This is a significant doctrinal shift. It means every service member — not just medics — needs to understand tourniquet assessment criteria. The days of "apply and forget" are explicitly over.
TCCC vs. TECC: What Is the Difference?
Direct answer: TCCC (Tactical Combat Casualty Care) is the U.S. military's combat trauma standard, maintained by the CoTCCC under the Joint Trauma System. TECC (Tactical Emergency Casualty Care) adapts those same principles for civilian high-threat environments — active shooter events, terrorism, and mass casualty incidents. TECC is maintained by the Committee for Tactical Emergency Casualty Care (C-TECC) and is used by law enforcement, civilian EMS, and first responders.
| Feature | TCCC | TECC |
|---|---|---|
| Primary Audience | U.S. military personnel, all service members, combat medics/corpsmen | Civilian law enforcement, EMS, fire, first responders, security |
| Governing Body | Committee on TCCC (CoTCCC) / Joint Trauma System (JTS), DHA | Committee for Tactical Emergency Casualty Care (C-TECC) |
| Phases of Care | Care Under Fire (CUF) → Tactical Field Care (TFC) → Tactical Evacuation Care (TACEVAC) | Direct Threat Care (DTC) / Hot Zone → Indirect Threat Care (ITC) / Warm Zone → Evacuation Care (EC) / Cold Zone |
| Assessment Framework | MARCH-PAWS (Massive hemorrhage, Airway, Respiration, Circulation, Hypothermia, Pain, All extremity checks, Wounds, Safety) | X-ABCDE or MARCH, scope-dependent |
| Airway in Hot/CUF Phase | Tourniquet only; no airway intervention under fire | DTC: hemorrhage control priority; recovery position for unresponsive |
| Advanced Airway (TFC/ITC) | No SGA (removed Change 24-1); cric with capnography if needed | Supraglottic airways remain optional in ITC/Warm Zone for qualified providers |
| Ketamine/TBI | Ketamine an option; enhanced TBI monitoring | Ketamine explicitly OK for TBI (no longer contraindicated); 0.3–0.4 mg/kg IN/IM |
| Calcium | Damage Control Resuscitation via CPG | 1g CaCl or 3g CaGlu with blood products for hemorrhagic shock (Jan 2025) |
| Pediatric-Specific Guidance | Adapted within general TCCC framework | Separate Pediatric TECC guidelines published January 2025 |
| Primary Reference | Deployed Medicine / JSOM | C-TECC.org |
Key TECC-Specific Updates: January 2025
C-TECC published its updated TECC Guidelines for BLS/ALS Clinicians on January 2, 2025, and the companion Pediatric TECC Guidelines on January 15, 2025. The most clinically significant changes:
- Recovery position in DTC (Hot Zone): Unresponsive casualties with signs of life should be placed in the recovery position even during the Direct Threat phase — a departure from prior "hands off" hot zone doctrine.
- Ketamine for TBI — no longer contraindicated: This is a major pharmacological update. Prior dogma held that ketamine raised intracranial pressure and was contraindicated in TBI. Current evidence does not support that concern. TECC 2025 explicitly endorses ketamine for analgesia in TBI at 0.3–0.4 mg/kg IN/IM or 0.1–0.2 mg/kg IV/IO.
- Calcium for hemorrhagic shock: When blood products are available per protocol, administer 1g 10% Calcium Chloride (13.65 mEq/10mL) or 3g 10% Calcium Gluconate slow IV push. Trauma-induced coagulopathy depletes ionized calcium, and replenishment significantly improves outcomes in massive transfusion.
- Tourniquet conversion after 2 hours: If evacuation is delayed beyond 2 hours and the casualty is responding to resuscitation (improving mentation, returning peripheral pulses), consider tourniquet downgrade. Expose the wound, place a new tourniquet 2–3 inches above the injury, and loosen but leave the original in place. Do not repeat if the first attempt fails.
- Pediatric adaptations: Separate pediatric guidelines now address age-specific communication, assessment, and post-trauma management — critical for law enforcement and EMS operating in school or community mass casualty scenarios.
For the full civilian tactical medicine picture — including how these guidelines integrate with existing TCCC and TECC updates covered in our 2025 overview — the baseline framework remains consistent across both systems.
The MARCH Algorithm: Still the Foundation — How Do the 2025–2026 Updates Affect Each Step?
Direct answer: MARCH remains the organizational backbone of TCCC assessment and care in Tactical Field Care. Every 2024–2026 update maps directly to a specific MARCH step, and understanding which step each change belongs to is the fastest way to integrate new guidance into your muscle memory and SOPs.
For a comprehensive breakdown of the MARCH algorithm itself, see our dedicated article: The MARCH Algorithm in Tactical Combat Casualty Care. Here we focus specifically on how the 2025–2026 updates interact with each step.
| MARCH Step | 2025–2026 Update | Operational Implication |
|---|---|---|
| M — Massive Hemorrhage | TXA: administer ASAP, no 3-hour restriction. Proposed Change 25-2: tourniquet reassessment within 2 hours for all service members. | Don't delay TXA for any reason. Reassess all tourniquets at the 2-hour mark — not just medics. |
| A — Airway | Change 24-1: Remove EGA from TFC. Recovery position for unconscious. "Sit-Up and Lean-Forward" for conscious maxillofacial trauma. No jaw thrust. Capnography mandatory after cric. | Simplify airway kit. Practice recovery positioning. Eliminate EGA from muscle memory and IFAK loadout. Add capnography to cric kits. |
| R — Respiration | NPA repositioned to Respiration section (SpO₂ <90% + BVM). 1,000 mL BVM specified. Resuscitation prioritized before decompression in clinical decision-making. | NPA is a respiratory adjunct, not an airway device. Carry a 1,000 mL BVM. Establish fluid status before reaching for the needle. |
| C — Circulation | Multimodal analgesia revision. Resuscitation emphasis. Whole blood / damage control resuscitation integration. | Know your unit's blood product access. Update analgesia protocols to multimodal approach. |
| H — Hypothermia / Head Injury | Enhanced TBI monitoring. Ketamine no longer contraindicated in TBI (TECC 2025 — TCCC guidance trending same direction). Prolonged Casualty Care (PCC) integration. | Ketamine is now an acceptable analgesia option even with suspected TBI. Early aggressive hypothermia prevention. Plan for PCC if evacuation is delayed. |
| Antibiotics (end of TFC) | Change 25-1: Ceftriaxone 2g IV/IO/IM (replaces ertapenem 1g). Cefadroxil 1g oral (replaces moxifloxacin). Prophylaxis recommended for all invasive procedures. | Remove ertapenem and moxifloxacin from kits. Stock ceftriaxone 2g vials. NS reconstitution only. Ensure prophylaxis for any IO, chest seal, or cric placement. |
What Do These Changes Mean for Your Training and Equipment?
Direct answer: The 2024–2026 TCCC guideline updates require concrete changes to your IFAK loadout, your unit's SOPs, and your personal training focus. The changes are not cosmetic — removing ertapenem from kits, eliminating EGA devices, adding capnography for cric procedures, and building 2-hour tourniquet reassessment into drills are all tangible action items.
Kit Implications
- Remove ertapenem, add ceftriaxone 2g: Ceftriaxone 2g vials reconstituted in NS only. Ensure your kit has sufficient NS for reconstitution (10 mL per gram). If carrying calcium-containing fluids (LR), ensure separate line or dedicated flush protocol.
- Remove moxifloxacin, add cefadroxil 1g: Cefadroxil offers better stability, similar spectrum, and lower side-effect profile. Cephalexin 500mg is the accepted alternative if cefadroxil is unavailable.
- Remove SGA/EGA devices from TFC IFAK: If your kit was stocked with I-gel or LMA-Supreme, remove them from TFC loadouts. They remain appropriate for some TECC providers in the Indirect Threat Care phase.
- Add capnography capability: Continuous EtCO₂ monitoring is now required after any cricothyroidotomy. Miniaturized capnography devices (e.g., Nonin, Nellcor, or compatible handheld units) should be part of any kit from which a cric may be performed.
- TXA availability: With the 3-hour restriction removed, the case for pre-hospital TXA auto-injectors in every IFAK grows stronger. The Army is actively exploring this. Until then, ensure accessible TXA in all medical kits.
- 1,000 mL BVM: The smaller BVM is now specified. If your kit has a 1,500 mL BVM, replace it.
Training Implications
- Drill recovery positioning: The lateral recovery position with head in extended (neutral-plus) position needs to be a reflexive skill. Practice it in PPE, at night, with simulated bulky casualties.
- Capnography competency: If your providers perform cricothyroidotomies, they must now train to continuous EtCO₂ monitoring. This is a new psychomotor skill requirement and must be evaluated.
- Tourniquet reassessment drills: Build 2-hour tourniquet reassessment scenarios into every TFC exercise. Non-medical service members need clear, scripted decision criteria for when to reassess, reposition, or call for medical assistance with conversion.
- Antibiotic reconstitution practice: Ceftriaxone reconstitution is not complicated, but it differs from ertapenem and must be practiced. Include drug reconstitution in simulation labs.
- TBI pain management: If your protocols previously defaulted to withholding ketamine for suspected TBI, update them. Train providers on the evidence and appropriate dosing.
How MED-TAC Training Integrates These Updates
At MED-TAC International Corp., our TCCC All Combatants and TCCC Medical Provider courses are continuously updated to reflect current CoTCCC guidelines. We don't wait for annual curriculum cycles — when the CoTCCC publishes, we update. Our courses currently incorporate all Change 24-1 and Change 25-1 content, including hands-on ceftriaxone reconstitution, recovery positioning under simulated stress, and capnography integration in surgical airway labs.
When updating your unit or agency SOPs for 2026, verify each of the following: (1) Ertapenem removed, ceftriaxone 2g added; (2) Moxifloxacin removed, cefadroxil 1g added; (3) EGA removed from TFC airway algorithm; (4) Recovery position added as first-line for unconscious without obstruction; (5) Capnography mandated post-cric; (6) TXA administered ASAP — no 3-hour restriction; (7) Tourniquet reassessment within 2 hours documented for all personnel; (8) 1,000 mL BVM specified in kit list.
How Do You Stay Current with TCCC Guidelines?
Direct answer: Official CoTCCC guideline updates are published through the Joint Trauma System, the Deployed Medicine platform, and the Journal of Special Operations Medicine. Changes are not automatically broadcast — staying current requires active engagement with authoritative sources. Here are the primary channels every tactical medicine professional should monitor.
Official Sources
- Deployed Medicine App (deployedmedicine.com): The official, DoD-sanctioned platform for current TCCC guidelines, cards, and education materials. Available on iOS, Android, and Google platforms. This is the authoritative source — not third-party summaries or outdated PDFs.
- Joint Trauma System (jts.health.mil): The CoTCCC committee page, Clinical Practice Guidelines (CPGs), and related publications are hosted here.
- Journal of Special Operations Medicine (jsomonline.org): Every formal TCCC change is published here as a peer-reviewed article with full rationale, evidence review, and level-of-evidence ratings. Changes are citable scientific documents.
- TCCC and Combat Casualty Care Podcast: Official CoTCCC audio updates — available in all major podcast applications. Excellent for staying current with proposed changes and working group discussions before they are formally published.
- C-TECC (c-tecc.org): For TECC-specific updates, the C-TECC website hosts all current guideline documents.
Training That Keeps You Current
Reading guidelines is necessary but not sufficient. Prehospital trauma care is a perishable psychomotor skill. The only way to maintain proficiency — and to actually integrate guideline changes into performance — is deliberate, regular training.
MED-TAC offers training programs aligned with the latest JTS-endorsed guidelines:
- TCCC All Combatants (Tier 1 / ASM level): Core life-saving skills for non-medical personnel. Updated to include current tourniquet reassessment criteria and recovery positioning.
- TCCC Medical Provider: Comprehensive course for medics, paramedics, nurses, and physicians. Incorporates Change 24-1 airway updates, Change 25-1 antibiotic protocols, and Prolonged Casualty Care considerations.
- Continuing education and unit training: Contact MED-TAC for customized unit training programs incorporating scenario-based simulation for 2026 guideline integration.
Monitor the JSOM PubMed feed and Deployed Medicine changelogs for "proposed changes" — the CoTCCC often publishes working group papers 6–12 months before a change is officially adopted. Incorporating proposed changes into training early means your team is never behind the curve.
Frequently Asked Questions About TCCC Guidelines
Q1: What is the latest version of the TCCC guidelines?
As of early 2026, the current TCCC guidelines incorporate Change 24-1 (airway management overhaul, published in JSOM Spring 2025), Change 25-1 (antibiotic revision — ceftriaxone and cefadroxil, published December 2025), and the TXA administration revision eliminating the 3-hour restriction. Proposed Change 25-2 (tourniquet reassessment standardization, published March 2026) is pending formal adoption. Always verify the current version at Deployed Medicine — the official DoD source for current TCCC materials.
Q2: What antibiotic does TCCC now recommend?
Under TCCC Change 25-1 (late 2025): ceftriaxone 2g IV/IO/IM once daily (parenteral) and cefadroxil 1g (oral, preferred) or cephalexin 500mg (oral, alternative). Ertapenem 1g and moxifloxacin have been removed from TCCC recommendations. Reconstitute ceftriaxone in NS only — not lactated Ringer's or any calcium-containing solution.
Q3: How often do TCCC guidelines change?
There is no fixed annual cycle. The CoTCCC issues changes based on the accumulation of sufficient evidence, battlefield experience, and working group review — which can happen at any time. Since 2001, the cadence has averaged roughly 1–3 substantive changes per year. The most active periods of change have followed major conflict operations (post-OEF/OIF) and, more recently, data emerging from the Russo-Ukrainian War. Subscribe to the Deployed Medicine changelog and the JSOM to receive notifications immediately upon publication.
Q4: What is the difference between TCCC and TECC?
TCCC is the U.S. military's prehospital trauma standard, governed by the CoTCCC under the Joint Trauma System (JTS). TECC adapts those principles for civilian high-threat environments and is maintained by the C-TECC. The core MARCH framework and hemorrhage-first philosophy are shared, but the phases, nomenclature, advanced airway options, and some pharmacological recommendations differ. See the comparison table in the TCCC vs. TECC section above for a full side-by-side breakdown.
Q5: Do civilian EMS agencies use TCCC?
Many do, particularly those serving law enforcement tactical teams or operating in high-threat environments. However, civilian EMS typically uses TECC as the direct-application framework, since it is designed for civilian scope-of-practice and legal environments. The CoTCCC has worked closely with civilian trauma initiatives including the Hartford Consensus and the White House Stop the Bleed campaign to ensure battlefield advances translate to civilian streets. Many urban EMS systems have adopted TCCC-derived hemorrhage control, tourniquet use, and TXA protocols.
Q6: Where can I get TCCC certified?
TCCC training is formally structured through the National Association of Emergency Medical Technicians (NAEMT), endorsed by the Joint Trauma System and the American College of Surgeons. Three tiers exist: TCCC-ASM (7 hours, all service members), TCCC-CLS (40 hours, Combat Lifesaver), and TCCC-CMC/TCCC-CPP (63–68 hours, medical personnel). MED-TAC International Corp. offers TCCC All Combatants and TCCC Medical Provider courses with all 2025–2026 guideline updates incorporated. Contact MED-TAC to schedule training for your unit or agency.
Q7: What is the CoTCCC and who is on it?
The Committee on Tactical Combat Casualty Care (CoTCCC) is the scientific body responsible for developing, reviewing, and updating TCCC guidelines. It operates under the Defense Health Agency's Joint Trauma System (JTS) and reports through the Defense Committee on Trauma (DCoT). Membership includes military trauma surgeons, emergency physicians, special operations medics, pharmacologists, infectious disease specialists, and nurse practitioners drawn from all service branches. The current Chair is reachable through the JTS at jts.health.mil. The committee convenes regularly to review proposed changes, with all adopted changes published in peer-reviewed form in the Journal of Special Operations Medicine.
Train to the Standard That Saves Lives
MED-TAC International Corp. offers TCCC and TECC training fully aligned with the latest 2025–2026 CoTCCC guidelines. From individual certification to full unit training packages, we teach this material because it matters.
View MED-TAC Training Read: The MARCH Algorithm Deep Dive1. Shaw TA et al. "Airway Management in Tactical Combat Casualty Care: TCCC Change 24-1." J Spec Oper Med. 2025 Apr 30;24(4):45–56. https://pubmed.ncbi.nlm.nih.gov/39688899/
2. Wisniewski et al. "Antibiotics in Tactical Combat Casualty Care 2025: TCCC Change 25-1." J Spec Oper Med. 2025 Dec. https://pubmed.ncbi.nlm.nih.gov/41474877/
3. Shertz M. "Why did the TCCC Committee Change Antibiotic Recommendations?" Crisis Medicine. 2026 Feb 26. https://www.crisis-medicine.com/tccc-2025-abx-changes/
4. Koch EJ et al. "Standardizing Tourniquet Reassessment and Conversion Across TCCC Tiers: TCCC Guidelines Proposed Change 25-2." J Spec Oper Med. 2026 Mar 12. https://pubmed.ncbi.nlm.nih.gov/41818038/
5. U.S. Army. "The Role of Tranexamic Acid in Future Combat Casualty Care." 2025 Jul 16. https://api.army.mil/e2/c/downloads/2025/07/16/...
6. Committee for Tactical Emergency Casualty Care (C-TECC). "TECC Guidelines for BLS/ALS Clinicians." Final 2025-1-2. https://www.c-tecc.org/images/F_TECC_ALS_BLS_Guidelines_2025_FINAL.pdf
7. C-TECC. "TECC Guidelines for Pediatric Patients." Final 2025-1-15. https://www.c-tecc.org/images/F_TECC_Peds_Guidelines_2025_FINAL.pdf
8. Butler FK et al. "Two Decades of Saving Lives on the Battlefield: Tactical Combat Casualty Care Turns 20." Military Medicine. 2017;182(3-4):e1563. https://academic.oup.com/milmed/article/182/3-4/e1563/4099581
9. Kotwal RS et al. "Eliminating Preventable Death on the Battlefield." JAMA Surgery. 2011;146(12):1350–1358. https://jamanetwork.com/journals/jamasurgery/fullarticle/1107258
10. Joint Trauma System. "Committee on Tactical Combat Casualty Care (CoTCCC)." https://jts.health.mil/index.cfm/committees/cotccc
11. NAEMT. "Tactical Combat Casualty Care." https://www.naemt.org/education/trauma-education/naemt-tccc
12. Deployed Medicine. https://deployedmedicine.com/market/226
Leave a comment